Conference
COST-UTILITY ANALYSIS OF AN ALL-PRETERM INFANT IMMUNIZATION WITH NIRSEVIMAB AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV): ASSOCIATED DISEASE AT THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Authors
Watanabe SF; Santoro J; Tolardo A; Safadi M; Stein RT; Falavigna M; Schneider NB; Marmett B; Soudani S
Volume
27
Pagination
pp. S216-S216
Publisher
ELSEVIER SCIENCE INC
Publication Date
December 1, 2024
Conference proceedings
VALUE IN HEALTH
Issue
12
ISSN
1098-3015